NOVIELLO, DANIELE
NOVIELLO, DANIELE
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
The long game in ulcerative colitis: mirikizumab's four-year outcomes
2026 D. Noviello, F. Caprioli
Ustekinumab and JAK inhibitors outperform vedolizumab as second-line therapy in anti-TNF-experienced patients with ulcerative colitis
2026 G. Privitera, C. Bezzio, G. Figlioli, F. D'Amico, J. Mendes, S. Varca, F. Zingone, I.R. Lago, S. Onali, F.A. Caprioli, M. Chaparro, M.B. Acosta, K. Karmiris, N.T. Degabli, L. Dar, L. Pastorelli, A. Gutiérrez, A. Orlando, Y. Zabana, S. Saibeni, D. Piovani, E.V. Savarino, D. Pugliese, F. Magro, S. Danese, A. Armuzzi, S. Bonovas, F. Fanizzi, P. Ferraz, F. Scaldaferri, B. Barberio, I. Moraleja, A. Favale, D. Noviello, J.P. Gisbert, M. Porto-Silva, A. Psistakis, H. Yanai, U. Kopylov, M. Di Pietro, L. Madero-Velázquez, F.S. Macaluso, R. Orlando, R. Gabbiadini, A.D. Buono, L. Loy, G. Migliorisi, C. Zoratti
Intestinal Barrier healing is superior to transmural healing to prevent disease progession in clinical remittent patients with IBD
2025 T. Orlemann, D. Zimmermann, H. Hübner, R. Atreya, J. Bodenschatz, D. Noviello, F. Vitali, D. Strobel, R. Janka, W. Uter, A. Hartmann, M. Neurath, T. Rath
Editorial: Targeting Urgency in IBD—A Historical Divide
2025 D. Noviello, R. Atreya
Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class
2025 T. Innocenti, J. Hanžel, M. Truyens, M. Lukaš, H. Gordon, A. Cremer, T. Molnár, M. Julsgaard, S. Onali, A. Todeschini, O.M. Nardone, N.M. Noor, F. Caprioli, F. Scaldaferri, K. Argyriou, E.V. Savarino, M. Brinar, C.R.H. Hedin, M. Vela González, A. Armuzzi, A. Blesl, A. Aratari, A. Quadarella, T.L. Parigi, L. Bertani, C. Ferracane, M. Uzzan, G. Michalopoulos, A. De Bernardi, K. Katsanos, P. Balestrieri, G. Piñero, K. Karmiris, A.G. Casbas, S. Nikolic, C. Felice, D. Pugliese, P. Pastras, G. Mocci, L. Pouillon, G.J. Mantzaris, L. Ramos, M.J. Casanova, I.E. Koutroubakis, M.J. García, N. Null, L. Bonacci, E. Bonazzi, P. Bossuyt, C. Bezzio, C.C. De Castro Gonçalves, M. Chaparro, T. Christos, A. Curto, S. Danese, B. Farkas, A. Favale, S. Festa, K. Foteinogiannopoulou, F. Fousekis, A. Kapsoritakis, Ž. Krznarić, L. Laterza, C. Liefferinckx, M. Mañosa, D. Noviello, L. Parisio, S. Saibeni, M.T. Sharip, E. Tettoni, T. Lobaton, G. Dragoni
Results of the 9th Scientific Workshop of the European Crohn’s and Colitis Organisation (ECCO): Artificial Intelligence in Endoscopy, Radiology and Histology in IBD Diagnostics
2025 A. Mookhoek, P. Sinonque, M. Allocca, D. Carter, A. Ensari, M. Iacucci, U. Kopylov, B. Verstockt, D.C. Baumgart, N.M. Noor, A. El-Hussuna, K. Sahnan, U.M. Marigorta, D. Noviello, P. Bossuyt, G. Pellino, A. Soriano, J. De Laffolie, M. Daperno, T. Raine, I. Cleynen, S. Sebastian
Results of the 9th Scientific Workshop of the European Crohn’s and Colitis Organisation (ECCO): Artificial Intelligence in IBD: Regulatory and Methodological Considerations
2025 N.M. Noor, M. Daperno, J. De Laffolie, A. Mookhoek, P. Sinonquel, U. Kopylov, B. Verstockt, A. El-Hussuna, K. Sahnan, M. Allocca, P. Bossuyt, D. Carter, A. Ensari, M. Iacucci, U.M. Marigorta, D. Noviello, G. Pellino, A. Soriano, I. Cleynen, T. Raine, S. Sebastian, D.C. Baumgart
Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicentre retrospective cohort study
2025 D. Noviello, M. Chaparro, C. Viganò, A. Blesl, B. Barberio, H. Yanai, A. Orlando, R. Ferreiro-Iglesias, C. Bezzio, A. Zilli, T. Molnár, C. Gheorghe, F. Conforti, T. Innocenti, S. Saibeni, P. Bossuyt, R. Oliveira, A.M. Carvalhas Gabrielli, A. Losco, S. Vieujean, E. Tettoni, L. Pirola, S. Calderone, M. Kornowski Cohen, G. Dragoni, T. Rath, M. Barreiro-de Acosta, E.V. Savarino, J.P. Gisbert, M. Vecchi, R. Atreya, F. Caprioli
Curing inflammatory bowel diseases: breaking the barriers of current therapies- emerging strategies for a definitive treatment
2025 D. Noviello, C. Amoroso, M. Vecchi, F. Facciotti, F. Caprioli
Results of the Ninth Scientific Workshop of the European Crohn’s and Colitis Organisation (ECCO): Artificial intelligence in IBD surgery: opportunities and limitations
2025 A. El-Hussuna, G. Pellino, A. Soriano, K. Sahnan, A. Mookhoek, P. Sinonque, M. Allocca, D. Carter, A. Ensari, M. Iacucci, U. Kopylov, B. Verstockt, D.C. Baumgart, N.M. Noor, U.M. Marigorta, D. Noviello, P. Bossuyt, J. De Laffolie, M. Daperno, T. Raine, I. Cleynen, S. Sebastian
Resolving loss of response to ustekinumab in Crohn’s disease: POWER through or switch treatment?
2025 D. Noviello, R. Atreya, N.M. Noor
Results of the 9th Scientific Workshop of the European Crohn’s and Colitis Organisation (ECCO): Artificial Intelligence in medical management and precision medicine
2025 U. Kopylov, B. Verstockt, U. Marigorta, D. Noviello, P. Bossuyt, A. Mookhoek, P. Sinonquel, A. El-Hussuna, K. Sahnan, D. Baumgart, N. M Noor, M. Allocca, D. Carter, A. Ensari, M. Iacucci, G. Pellino, A. Soriano, J. De Laffolie, M. Daperno, T. Raine, I. Cleynen, S. Sebastian
Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC)
2025 D. Noviello, W. Fries, A. Orlando, F.S. Conforti, C. Bezzio, F. Castiglione, M.C. Fantini, E.V. Savarino, S. Festa, D.G. Ribaldone, G. Mocci, L. Grossi, C. Viganò, N. Imperatore, L. Ceccarelli, A.M. Carvalhas Gabrielli, G. Scardino, S. Saibeni, P. Balestrieri, M. Principi, M. Campigotto, A.G. Gravina, R. Spagnuolo, F. Scaldaferri, B. Neri, A. Di Sario, M. Baldoni, R. Di Mitri, E. Tettoni, S. Calderone, A. Armuzzi, F.S. Macaluso, M. Vecchi, M. Ventimiglia, F. Caprioli, C. De Francesco, N. Piazza O Sed, G. Marcozzi, A.D. Guarino, S. Onali, C. De Barba, G. Orrù, A. Laffusa
AIEC-dependent pTh17 cells generation relies on distinct virulence-determinants implicated in persistence and inflammatory response of intestinal epithelial cells and macrophages
2024 I. Dusetti, D. Noviello, D. Dolfini, N. Barnich, E. Billard, C. Consolandi, F. Facciotti, F. Caprioli, M. Paroni
Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study
2024 M. Allocca, G. Catalano, E.V. Savarino, M. Chaparro, A. Levartovsky, G. Michalopoulos, N. Viazis, F.S. Fousekis, A. Psistakis, D. Noviello, C.N.D. Nascimento, B. Caron, V. Kitsou, G. Bamias, M.J. García, E. Zacharopoulou, K. Foteinogiannopoulou, F. D'Amico, I. Koutroubakis, P. Ellul, M. Tzouvala, L. Peyrin-Biroulet, J. Torres, F. Caprioli, K. Karmiris, A. Theodoropoulou, K.H. Katsanos, D.K. Christodoulou, G.J. Mantzaris, U. Kopylov, J.P. Gisbert, S. Danese, F. Magro, F. Carla, G. Fiorino
AIEC-dependent pathogenic Th17 cell transdifferentiation in Crohn's disease is suppressed by rfaP and ybaT deletion
2024 G. Leccese, M. Chiara, I. Dusetti, D. Noviello, E. Billard, A. Bibi, G. Conte, C. Consolandi, M. Vecchi, M.P. Conte, N. Barnich, F. Caprioli, F. Facciotti, M. Paroni
Risankizumab, but not ustekinumab or vedolizumab, downregulates IL-23-induced mucosal pathogenic Th17 cells in patients with Crohn’s disease
2024 D. Noviello, I. Dusetti, V. Pivorunas, A.E. Lovati, C. Ciafardini, C. Amoroso, F. Conforti, N. Piazza O Sed, M. Vecchi, F. Facciotti, M. Paroni, F. Caprioli
Rates of adverse events in patients with ulcerative colitis undergoing colectomy during treatment with tofacitinib vs biologics: a multicenter observational study
2024 G. Dragoni, T. Innocenti, A. Amiot, F. Castiglione, L. Melotti, S. Festa, E.V. Savarino, M. Truyens, K. Argyriou, D. Noviello, T. Molnar, V. Bouillon, C. Bezzio, P. Eder, S. Fernandes, A. Kagramanova, A. Armuzzi, R. Oliveira, A. Viola, D.G. Ribaldone, I. Drygiannakis, C. Viganò, F. Calella, A.G. Gravina, D. Pugliese, M. Chaparro, P. Ellul, S. Vieujean, M. Milla, F. Caprioli
The carbon cost of inappropriate endoscopy
2024 L. Elli, S. La Mura, A. Rimondi, L. Scaramella, G. Tontini, F. Monica, M. Soncini, M. Topa, F. Bortoluzzi, A. Sorge, F. Cavallaro, N. Nandi, D. Noviello, A. Piagnani, M. Maregatti, M. Caldato, M. Vecchi
Gut virome-colonisingOrthohepadnavirusgenus is associated with ulcerative colitis pathogenesis and induces intestinal inflammationin vivo
2023 L. Massimino, O. Palmieri, A. Facoetti, D. Fuggetta, S. Spanò, L.A. Lamparelli, S. D'Alessio, S. Cagliani, F. Furfaro, F. D'Amico, A. Zilli, G. Fiorino, T.L. Parigi, D. Noviello, A. Latiano, F. Bossa, T. Latiano, A. Pirola, L. Mologni, R.G. Piazza, D. Abbati, F. Perri, C. Bonini, L. Peyrin-Biroulet, A. Malesci, V. Jairath, S. Danese, F. Ungaro